めまい症例におけるセロクラールの使用経験

DOI Web Site

書誌事項

タイトル別名
  • Clinical Effects of Cerocral on Vertigious Patients
  • メマイ ショウレイ ニ オケル セロクラール ノ シヨウ ケイケン

この論文をさがす

抄録

Cerocral (ifenprodil tartrate), an agent which improves circulation in the region of vertebral arteries, was clinically studied in 23 vertigious patients. The therapeutic effects of Cerocral were investigated in 4 cases of hypertension, 2 cases of hypotention, 7 cases of vascular diseases of the brain stem or cerebellum, 5 cases of vertebuao-basilar insufficiency, one case of head injury, 3 cases of otogenic vertigo and one case of unknown origin.<br>Subjective symptoms improved in 78.3% of the 23 cases and objective symptoms in 82.6%. The final overall improvement rate was 82.6%.<br>Cerocral was more effective in patients with vertigo due to central origin than in otogenic vertigo. This tendency could be observed not only in subjective and objective symptoms but also in overall estimation. The therapeutic effects on vertigo and dizziness were better than on the cochlear symptoms. The effects on associate symptoms came between these two.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ